vs
Side-by-side financial comparison of PLUS THERAPEUTICS, INC. (PSTV) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $881.5K, roughly 1.6× Serve Robotics Inc.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -3888.1%, a 3470.2% gap on every dollar of revenue. On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs -3.2%). PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-46.1M). Over the past eight quarters, Serve Robotics Inc.'s revenue compounded faster (-3.5% CAGR vs -9.7%).
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
PSTV vs SERV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $881.5K |
| Net Profit | $-5.7M | $-34.3M |
| Gross Margin | — | -757.3% |
| Operating Margin | -420.0% | -4572.1% |
| Net Margin | -417.9% | -3888.1% |
| Revenue YoY | -3.2% | 400.1% |
| Net Profit YoY | -46.4% | -161.3% |
| EPS (diluted) | $0.95 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $881.5K | ||
| Q3 25 | $1.4M | $687.0K | ||
| Q2 25 | $1.4M | $642.0K | ||
| Q1 25 | $1.1M | $440.5K | ||
| Q4 24 | $1.4M | $176.3K | ||
| Q3 24 | $1.5M | $222.0K | ||
| Q2 24 | $1.3M | $468.0K | ||
| Q1 24 | $1.7M | $946.7K |
| Q4 25 | $-5.7M | $-34.3M | ||
| Q3 25 | $-4.4M | $-33.0M | ||
| Q2 25 | $5.2M | $-20.9M | ||
| Q1 25 | $-17.4M | $-13.2M | ||
| Q4 24 | $-3.9M | $-13.1M | ||
| Q3 24 | $-2.9M | $-8.0M | ||
| Q2 24 | $-2.9M | $-9.0M | ||
| Q1 24 | $-3.3M | $-9.0M |
| Q4 25 | — | -757.3% | ||
| Q3 25 | — | -637.4% | ||
| Q2 25 | — | -445.3% | ||
| Q1 25 | — | -333.4% | ||
| Q4 24 | — | -371.7% | ||
| Q3 24 | — | -70.3% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 62.8% |
| Q4 25 | -420.0% | -4572.1% | ||
| Q3 25 | -320.8% | -5067.8% | ||
| Q2 25 | -110.6% | -3527.1% | ||
| Q1 25 | -333.9% | -3406.6% | ||
| Q4 24 | -276.2% | -7701.3% | ||
| Q3 24 | -260.9% | -3804.1% | ||
| Q2 24 | -289.1% | -1828.2% | ||
| Q1 24 | -196.7% | -814.6% |
| Q4 25 | -417.9% | -3888.1% | ||
| Q3 25 | -316.6% | -4806.4% | ||
| Q2 25 | 370.6% | -3247.7% | ||
| Q1 25 | -1643.2% | -3000.5% | ||
| Q4 24 | -276.4% | -7441.8% | ||
| Q3 24 | -197.4% | -3601.8% | ||
| Q2 24 | -229.9% | -1931.2% | ||
| Q1 24 | -194.5% | -954.7% |
| Q4 25 | $0.95 | $-0.50 | ||
| Q3 25 | $-0.04 | $-0.54 | ||
| Q2 25 | $-0.01 | $-0.36 | ||
| Q1 25 | $-1.19 | $-0.23 | ||
| Q4 24 | $-0.51 | $-0.23 | ||
| Q3 24 | $-0.37 | $-0.20 | ||
| Q2 24 | $-0.71 | $-0.27 | ||
| Q1 24 | $-0.75 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.0M | $350.7M |
| Total Assets | $16.3M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $106.2M | ||
| Q3 25 | $16.6M | $116.8M | ||
| Q2 25 | $6.9M | $116.7M | ||
| Q1 25 | $9.9M | $197.8M | ||
| Q4 24 | $3.6M | $123.3M | ||
| Q3 24 | $4.8M | $50.9M | ||
| Q2 24 | $8.4M | $28.8M | ||
| Q1 24 | $3.2M | — |
| Q4 25 | $4.0M | $350.7M | ||
| Q3 25 | $5.1M | $283.9M | ||
| Q2 25 | $3.0M | $207.2M | ||
| Q1 25 | $-23.6M | $210.2M | ||
| Q4 24 | $-8.9M | $131.7M | ||
| Q3 24 | $-5.2M | $56.2M | ||
| Q2 24 | $-7.6M | $28.5M | ||
| Q1 24 | $-4.8M | $-8.8M |
| Q4 25 | $16.3M | $367.8M | ||
| Q3 25 | $18.7M | $299.1M | ||
| Q2 25 | $10.3M | $214.3M | ||
| Q1 25 | $12.1M | $216.6M | ||
| Q4 24 | $6.6M | $139.6M | ||
| Q3 24 | $7.0M | $61.5M | ||
| Q2 24 | $11.2M | $32.8M | ||
| Q1 24 | $5.6M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-29.6M |
| Free Cash FlowOCF − Capex | $-6.3M | $-46.1M |
| FCF MarginFCF / Revenue | -459.9% | -5234.4% |
| Capex IntensityCapex / Revenue | 2.2% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.8M | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.3M | $-29.6M | ||
| Q3 25 | $-2.5M | $-25.2M | ||
| Q2 25 | $-5.8M | $-16.0M | ||
| Q1 25 | $-6.2M | $-9.5M | ||
| Q4 24 | $-1.2M | $-6.3M | ||
| Q3 24 | $-3.7M | $-5.5M | ||
| Q2 24 | $-1.1M | $-5.7M | ||
| Q1 24 | $-4.5M | $-4.1M |
| Q4 25 | $-6.3M | $-46.1M | ||
| Q3 25 | $-2.6M | $-36.5M | ||
| Q2 25 | $-5.8M | $-22.0M | ||
| Q1 25 | $-6.2M | $-12.9M | ||
| Q4 24 | $-1.2M | $-11.1M | ||
| Q3 24 | $-3.7M | $-10.1M | ||
| Q2 24 | $-1.2M | $-6.5M | ||
| Q1 24 | $-4.6M | $-4.1M |
| Q4 25 | -459.9% | -5234.4% | ||
| Q3 25 | -184.3% | -5314.1% | ||
| Q2 25 | -417.6% | -3426.8% | ||
| Q1 25 | -583.1% | -2934.1% | ||
| Q4 24 | -86.5% | -6307.8% | ||
| Q3 24 | -253.7% | -4529.7% | ||
| Q2 24 | -96.2% | -1396.6% | ||
| Q1 24 | -271.5% | -431.1% |
| Q4 25 | 2.2% | 1872.1% | ||
| Q3 25 | 1.9% | 1649.6% | ||
| Q2 25 | 0.5% | 940.4% | ||
| Q1 25 | 0.3% | 785.7% | ||
| Q4 24 | 0.8% | 2755.1% | ||
| Q3 24 | 1.0% | 2070.7% | ||
| Q2 24 | 6.3% | 169.8% | ||
| Q1 24 | 2.4% | 0.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.13× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
